Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Covington
Mallinckrodt
Moodys
Julphar
Daiichi Sankyo
Fish and Richardson
UBS
McKesson

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072097

« Back to Dashboard

NDA 072097 describes CAP-PROFEN, which is a drug marketed by Perrigo and is included in one NDA. Additional details are available on the CAP-PROFEN profile page.

The generic ingredient in CAP-PROFEN is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and sixty-six suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
Summary for 072097
Tradename:CAP-PROFEN
Applicant:Perrigo
Ingredient:ibuprofen
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength200MG
Approval Date:Dec 8, 1987TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Argus Health
Harvard Business School
Federal Trade Commission
US Army
Queensland Health
Colorcon
Chubb
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.